Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratracheal lidocaine for prevention of pulmonary infection in mechanically ventilated trauma patients
IRCT20201013049017N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of lidocaine in pulmonary infection (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Reduction of pulmonary infection. Started Aug 2022; status: completed.
02
Drugs
lidocaine
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on IRCT20201013049017N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201013049017N2.